Physician profile
Danielle Moon
NPI 1780200188
$408.51
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $88.10 · 2023: $29.40 · 2024: $43.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $88.58 | 2021 | |
| Urovant Sciences INC | $84.67 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $53.72 | 2021 | |
| Acadia Pharmaceuticals INC | $32.94 | 2023-2024 | Nuplazid |
| Glaxosmithkline, LLC. | $30.62 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $26.33 | 2024 | Dupixent |
| Insmed, INC. | $16.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.09 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.72 | 2021 | |
| Mylan Specialty L.P. | $15.55 | 2021 | |
| Harmony Biosciences LLC | $14.24 | 2021 | |
| Sumitomo Pharma America, INC. | $13.81 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.